Oxford BioMedica says patent suit brought by Bavarian Nordic is dismissed

Oxford BioMedica Plc said that a patent infringement suit brought against it by Bavarian Nordic A/S of Denmark has been dismissed. The suit alleged that the UK company had infringed three of Bavarian Nordic’s US patents for a viral vector used in the Danish company’s smallpox, HIV and cancer programmes.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom